FDA Approved: WINLEVI — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for WINLEVI (clascoterone) by Sun Pharmaceutical Industries, expanding its labeling for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Winlevi (clascoterone)

Snippet

SUPPL AP for WINLEVI (CLASCOTERONE)